Clinical Trial Update: Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

This entry reports an ongoing Phase 2 clinical trial evaluating the combination of IM-862 with chemotherapy for patients with resected stage III ovarian cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• IM-862

Snippet

Sponsor: Cytran | Conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | Status: UNKNOWN